世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Onychomycosis Treatment Market Insights, Competitive Landscape, and Market Forecast - 2033
The global Onychomycosis Treatment Market is experiencing robust growth, fueled by the increasing prevalence of fungal nail infections, rising awareness about early diagnosis, and advancements in t... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global Onychomycosis Treatment Market is experiencing robust growth, fueled by the increasing prevalence of fungal nail infections, rising awareness about early diagnosis, and advancements in therapeutic approaches. Onychomycosis, caused by dermatophytes, yeasts, or non-dermatophyte molds, affects millions worldwide, leading to discomfort, aesthetic concerns, and complications in immunocompromised individuals. The market is projected to reach USD 4.3 billion in 2026 and grow to USD 6.1 billion by 2033, registering a CAGR of 5.1% during the forecast period.Market Insights The market encompasses a diverse range of treatment options, including oral drugs, topical therapies, and advanced procedures such as laser and photodynamic therapy. Oral antifungal medications continue to dominate due to their high efficacy, while topical treatments are increasingly preferred for patients seeking localized therapy with minimal systemic side effects. Meanwhile, laser and photodynamic therapies are emerging as promising alternatives, offering faster recovery times and lower recurrence rates. Market Drivers Several key factors are driving the growth of the Onychomycosis Treatment Market. The rising incidence of fungal nail infections, particularly among the aging population, is a primary factor. Lifestyle-related risks, including the use of occlusive footwear and exposure to communal environments such as gyms and swimming pools, contribute to higher infection rates. Increased awareness among patients and healthcare providers regarding treatment options and early intervention is further boosting market demand. Technological advances in laser and photodynamic therapy devices also present new opportunities for clinical adoption. Business Opportunities The market offers substantial opportunities for pharmaceutical companies, medical device manufacturers, and healthcare providers. Development of new antifungal drugs with improved efficacy and reduced side effects is a key area of focus. Additionally, expanding outpatient clinics and ambulatory surgery centers provides potential for delivering laser-based treatments more broadly. Collaborations between pharmaceutical companies and dermatology clinics can enhance market reach and patient compliance. Furthermore, the growth of telemedicine and e-pharmacy platforms improves access to prescription treatments, enabling patients to begin therapy more efficiently. Regional Analysis North America is expected to hold a significant market share, supported by high healthcare spending, advanced medical infrastructure, and strong patient awareness. Europe is also a key market, driven by an aging population and favorable regulatory support. The Asia Pacific region offers substantial growth potential due to rising disposable incomes, expanding healthcare infrastructure, and increasing prevalence of fungal infections. Latin America and the Middle East & Africa are projected to experience steady growth as awareness campaigns and healthcare investments enhance diagnosis and treatment adoption. Key Players The Onychomycosis Treatment Market is highly competitive, with several leading pharmaceutical companies actively engaging in research, product development, and strategic collaborations. Major market players include: • Pfizer Inc. • Novartis AG • GlaxoSmithKline plc (GSK) • Bayer AG • Johnson & Johnson • Merck & Co., Inc. • Sanofi S.A. • Astellas Pharma Inc. • Teva Pharmaceutical Industries Ltd. • AbbVie Inc. • Roche Holding AG • Eli Lilly and Company • Cipla Limited • Sun Pharmaceutical Industries Ltd. • Dr. Reddy’s Laboratories Market Segmentation By Treatment • Drugs • Topicals • Laser & Photodynamic Therapy • Others By Disease • Distal Subungual Onychomycosis • Proximal Subungual Onychomycosis • White Superficial Onychomycosis • Others By End-User • Hospitals • Specialty Clinics • Ambulatory Surgery Centers (ASCs) • Others By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Onychomycosis Treatment Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Fiver Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Onychomycosis Treatment Market Outlook, 2020 - 2033 3.1. Global Onychomycosis Treatment Market Outlook, by Treatment, Value (US$ Bn), 2020-2033 3.1.1. Drugs 3.1.2. Topicals 3.1.3. Laser & Photodynamic Therapy 3.1.4. Others 3.2. Global Onychomycosis Treatment Market Outlook, by Disease, Value (US$ Bn), 2020-2033 3.2.1. Distal Subungual Onychomycosis 3.2.2. Proximal Subungual Onychomycosis 3.2.3. White Superficial Onychomycosis 3.2.4. Others 3.3. Global Onychomycosis Treatment Market Outlook, by End-User, Value (US$ Bn), 2020-2033 3.3.1. Hospitals 3.3.2. Specialty Clinics 3.3.3. Ambulatory Surgery Centers (ASCs) 3.3.4. Others 3.4. Global Onychomycosis Treatment Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Latin America 3.4.5. Middle East & Africa 4. North America Onychomycosis Treatment Market Outlook, 2020 - 2033 4.1. North America Onychomycosis Treatment Market Outlook, by Treatment, Value (US$ Bn), 2020-2033 4.1.1. Drugs 4.1.2. Topicals 4.1.3. Laser & Photodynamic Therapy 4.1.4. Others 4.2. North America Onychomycosis Treatment Market Outlook, by Disease, Value (US$ Bn), 2020-2033 4.2.1. Distal Subungual Onychomycosis 4.2.2. Proximal Subungual Onychomycosis 4.2.3. White Superficial Onychomycosis 4.2.4. Others 4.3. North America Onychomycosis Treatment Market Outlook, by End-User, Value (US$ Bn), 2020-2033 4.3.1. Hospitals 4.3.2. Specialty Clinics 4.3.3. Ambulatory Surgery Centers (ASCs) 4.3.4. Others 4.4. North America Onychomycosis Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.4.1. U.S. Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 4.4.2. U.S. Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 4.4.3. U.S. Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 4.4.4. Canada Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 4.4.5. Canada Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 4.4.6. Canada Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 4.5. BPS Analysis/Market Attractiveness Analysis 5. Europe Onychomycosis Treatment Market Outlook, 2020 - 2033 5.1. Europe Onychomycosis Treatment Market Outlook, by Treatment, Value (US$ Bn), 2020-2033 5.1.1. Drugs 5.1.2. Topicals 5.1.3. Laser & Photodynamic Therapy 5.1.4. Others 5.2. Europe Onychomycosis Treatment Market Outlook, by Disease, Value (US$ Bn), 2020-2033 5.2.1. Distal Subungual Onychomycosis 5.2.2. Proximal Subungual Onychomycosis 5.2.3. White Superficial Onychomycosis 5.2.4. Others 5.3. Europe Onychomycosis Treatment Market Outlook, by End-User, Value (US$ Bn), 2020-2033 5.3.1. Hospitals 5.3.2. Specialty Clinics 5.3.3. Ambulatory Surgery Centers (ASCs) 5.3.4. Others 5.4. Europe Onychomycosis Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.4.1. Germany Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 5.4.2. Germany Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 5.4.3. Germany Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 5.4.4. Italy Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 5.4.5. Italy Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 5.4.6. Italy Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 5.4.7. France Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 5.4.8. France Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 5.4.9. France Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 5.4.10. U.K. Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 5.4.11. U.K. Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 5.4.12. U.K. Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 5.4.13. Spain Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 5.4.14. Spain Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 5.4.15. Spain Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 5.4.16. Russia Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 5.4.17. Russia Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 5.4.18. Russia Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 5.4.19. Rest of Europe Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 5.4.20. Rest of Europe Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 5.4.21. Rest of Europe Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 5.5. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Onychomycosis Treatment Market Outlook, 2020 - 2033 6.1. Asia Pacific Onychomycosis Treatment Market Outlook, by Treatment, Value (US$ Bn), 2020-2033 6.1.1. Drugs 6.1.2. Topicals 6.1.3. Laser & Photodynamic Therapy 6.1.4. Others 6.2. Asia Pacific Onychomycosis Treatment Market Outlook, by Disease, Value (US$ Bn), 2020-2033 6.2.1. Distal Subungual Onychomycosis 6.2.2. Proximal Subungual Onychomycosis 6.2.3. White Superficial Onychomycosis 6.2.4. Others 6.3. Asia Pacific Onychomycosis Treatment Market Outlook, by End-User, Value (US$ Bn), 2020-2033 6.3.1. Hospitals 6.3.2. Specialty Clinics 6.3.3. Ambulatory Surgery Centers (ASCs) 6.3.4. Others 6.4. Asia Pacific Onychomycosis Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.4.1. China Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 6.4.2. China Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 6.4.3. China Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 6.4.4. Japan Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 6.4.5. Japan Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 6.4.6. Japan Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 6.4.7. South Korea Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 6.4.8. South Korea Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 6.4.9. South Korea Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 6.4.10. India Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 6.4.11. India Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 6.4.12. India Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 6.4.13. Southeast Asia Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 6.4.14. Southeast Asia Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 6.4.15. Southeast Asia Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 6.4.16. Rest of SAO Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 6.4.17. Rest of SAO Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 6.4.18. Rest of SAO Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 6.5. BPS Analysis/Market Attractiveness Analysis 7. Latin America Onychomycosis Treatment Market Outlook, 2020 - 2033 7.1. Latin America Onychomycosis Treatment Market Outlook, by Treatment, Value (US$ Bn), 2020-2033 7.1.1. Drugs 7.1.2. Topicals 7.1.3. Laser & Photodynamic Therapy 7.1.4. Others 7.2. Latin America Onychomycosis Treatment Market Outlook, by Disease, Value (US$ Bn), 2020-2033 7.2.1. Distal Subungual Onychomycosis 7.2.2. Proximal Subungual Onychomycosis 7.2.3. White Superficial Onychomycosis 7.2.4. Others 7.3. Latin America Onychomycosis Treatment Market Outlook, by End-User, Value (US$ Bn), 2020-2033 7.3.1. Hospitals 7.3.2. Specialty Clinics 7.3.3. Ambulatory Surgery Centers (ASCs) 7.3.4. Others 7.4. Latin America Onychomycosis Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.4.1. Brazil Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 7.4.2. Brazil Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 7.4.3. Brazil Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 7.4.4. Mexico Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 7.4.5. Mexico Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 7.4.6. Mexico Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 7.4.7. Argentina Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 7.4.8. Argentina Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 7.4.9. Argentina Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 7.4.10. Rest of LATAM Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 7.4.11. Rest of LATAM Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 7.4.12. Rest of LATAM Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 7.5. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Onychomycosis Treatment Market Outlook, 2020 - 2033 8.1. Middle East & Africa Onychomycosis Treatment Market Outlook, by Treatment, Value (US$ Bn), 2020-2033 8.1.1. Drugs 8.1.2. Topicals 8.1.3. Laser & Photodynamic Therapy 8.1.4. Others 8.2. Middle East & Africa Onychomycosis Treatment Market Outlook, by Disease, Value (US$ Bn), 2020-2033 8.2.1. Distal Subungual Onychomycosis 8.2.2. Proximal Subungual Onychomycosis 8.2.3. White Superficial Onychomycosis 8.2.4. Others 8.3. Middle East & Africa Onychomycosis Treatment Market Outlook, by End-User, Value (US$ Bn), 2020-2033 8.3.1. Hospitals 8.3.2. Specialty Clinics 8.3.3. Ambulatory Surgery Centers (ASCs) 8.3.4. Others 8.4. Middle East & Africa Onychomycosis Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.4.1. GCC Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 8.4.2. GCC Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 8.4.3. GCC Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 8.4.4. South Africa Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 8.4.5. South Africa Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 8.4.6. South Africa Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 8.4.7. Egypt Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 8.4.8. Egypt Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 8.4.9. Egypt Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 8.4.10. Nigeria Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 8.4.11. Nigeria Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 8.4.12. Nigeria Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 8.4.13. Rest of Middle East Onychomycosis Treatment Market Outlook, by Treatment, 2020-2033 8.4.14. Rest of Middle East Onychomycosis Treatment Market Outlook, by Disease, 2020-2033 8.4.15. Rest of Middle East Onychomycosis Treatment Market Outlook, by End-User, 2020-2033 8.5. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Pfizer Inc. 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. Novartis AG 9.4.3. GlaxoSmithKline plc (GSK) 9.4.4. Bayer AG 9.4.5. Johnson & Johnson 9.4.6. Merck & Co., Inc. 9.4.7. Sanofi S.A. 9.4.8. Astellas Pharma Inc. 9.4.9. Teva Pharmaceutical Industries Ltd. 9.4.10. AbbVie Inc. 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Fairfield Market Research社の 医薬品・バイオテクノロジー分野 での最新刊レポート
本レポートと同じKEY WORD（landscape）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
